Artiva Biotherapeutics's three largest insider shareholders as of May 30, 2026 are Corp. Gc (TenPercentOwner, 4.57Mn shares), Yong-Jun Huh (Director, 4.57Mn shares), Partners Vi, Llc 5Am (TenPercentOwner, 2.35Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Management, L.P. Ra | - | 0 | 826,832 | 24 Jul, 2024 |
| Thorsten Graef | Chief Medical Officer | 80,000 | 0 | 27 Feb, 2025 |
| Jennifer Bush | Coo, Clo, Secy, Compliance Off | 346,710 | 0 | 18 Feb, 2026 |
| Thad Allen Huston | Chief Financial Officer | 220,000 | 0 | 10 Mar, 2026 |
| Christopher Horan | Chief Tech Operations Officer | 300,452 | 0 | 18 Feb, 2026 |
| Global Strategic Fund Iii, L.P. Venbio | - | 1,936,637 | 0 | 22 Jul, 2024 |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | - | 194,108 | 0 | 22 Jul, 2024 |
| Partners Vi, Llc 5Am | - | 0 | 2,353,304 | 24 Jul, 2024 |
| Neha Krishnamohan | Chief Financial Officer | 99,356 | 0 | 17 Nov, 2025 |
| Fred Aslan | President And Ceo | 1,562,198 | 0 | 18 Feb, 2026 |
| Yong-Jun Huh | - | 0 | 4,567,412 | 22 Jul, 2024 |
| Corp. Gc | - | 3,306,900 | 1,260,512 | 22 Jul, 2024 |
| Heather Raymon | Svp, Research And Development | 151,323 | 0 | 18 Feb, 2026 |
| Subhashis Banerjee | Chief Medical Officer | 152,000 | 0 | 18 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Mar, 2026 | Thad Allen Huston | Common Stock | A | 220,000 | $0.00 | 220,000 | D | A |
| 18 Feb, 2026 | Elaine K. Sorg | Director Stock Option (Right to Buy) | A | 27,500 | $0.00 | 27,500 | D | A |
| 18 Feb, 2026 | Elaine K. Sorg | Director Stock Option (Right to Buy) | A | 27,500 | $0.00 | 27,500 | D | A |
| 15 Feb, 2026 | Fred Aslan | Common Stock | A | 366,850 | $0.00 | 1,576,798 | D | A |
| 15 Feb, 2026 | Christopher Horan | Common Stock | A | 117,300 | $0.00 | 302,639 | D | A |
| 15 Feb, 2026 | Christopher Horan | Common Stock | A | 117,300 | $0.00 | 302,639 | D | A |
| 15 Feb, 2026 | Heather Raymon | Common Stock | A | 46,000 | $0.00 | 152,844 | D | A |
| 15 Feb, 2026 | Jennifer Bush | Common Stock | A | 117,300 | $0.00 | 350,225 | D | A |
| 15 Feb, 2026 | Subhashis Banerjee | Common Stock | A | 102,000 | $0.00 | 152,000 | D | A |
| 15 Feb, 2026 | Fred Aslan | Common Stock | A | 366,850 | $0.00 | 1,576,798 | D | A |
| 15 Feb, 2026 | Heather Raymon | Common Stock | A | 46,000 | $0.00 | 152,844 | D | A |
| 15 Feb, 2026 | Subhashis Banerjee | Common Stock | A | 102,000 | $0.00 | 152,000 | D | A |
| 15 Feb, 2026 | Fred Aslan | Common Stock | D | 14,600 | $4.00 | 1,562,198 | D | F |
| 15 Feb, 2026 | Heather Raymon | Common Stock | D | 1,521 | $4.00 | 151,323 | D | F |
| 15 Feb, 2026 | Fred Aslan | Common Stock | D | 14,600 | $4.00 | 1,562,198 | D | F |
| 15 Feb, 2026 | Christopher Horan | Common Stock | D | 2,187 | $4.00 | 300,452 | D | F |
| 15 Feb, 2026 | Jennifer Bush | Common Stock | D | 3,515 | $4.00 | 346,710 | D | F |
| 15 Feb, 2026 | Christopher Horan | Common Stock | D | 2,187 | $4.00 | 300,452 | D | F |
| 15 Feb, 2026 | Heather Raymon | Common Stock | D | 1,521 | $4.00 | 151,323 | D | F |
| 15 Dec, 2025 | Fred Aslan | Common Stock | D | 3,187 | $6.00 | 1,209,948 | D | S |